20 November 2018 Analysis
Heart disease is one of the leading causes of death in men and women, but women are commonly underrepresented in clinical trials. Could this negatively impact the treatment of female...
5 October 2018 Comment
The Asia-Pacific market for heart failure therapeutics was estimated at $733.7 million in 2017 and is projected to reach $1,435.9 million in 2024, increasing at a compound annual growth rate...
20 September 2018 projects
Germany-based pharmaceutical company, Boehringer Ingelheim, is constructing a new tablet production facility in Ingelheim, Germany, with an estimated investment of more than €85m ($97.2m).
18 September 2018 News
Monash University in Australia has reported initial results from a large clinical trial (ASPREE) performed to investigate the benefits and risks of low, daily doses of aspirin in healthy people...
28 August 2018 News
A new phase III clinical trial has demonstrated that Pfizer’s tafamidis drug can lower the risk of death in patients suffering from rare heart condition transthyretin amyloid cardiomyopathy.
10 August 2018 projects
US-based biopharmaceutical company Amgen is developing a bio-manufacturing facility at its campus in West Greenwich, Rhode Island, US.
3 July 2018 News
The Broad Institute of MIT and Harvard have expanded its strategic partnership with Bayer to launch the new Precision Cardiology Laboratory (PCL), which focuses on developing new therapeutics for heart...
26 June 2018 projects
In August 2014, Merck Serono began constructing a new pharmaceutical manufacturing facility in Nantong, China.
5 June 2018 News
The University of Dundee has reported results from two clinical trials indicating the use of a common, inexpensive diabetes drug metformin for heart and circulatory disease patients in the UK.
4 May 2018 projects
In August 2016, German pharmaceutical company Fresenius Kabi announced a proposal to expand its pharmaceutical manufacturing capabilities at the Melrose Park village site in Illinois, US.